Software for predicting tumor development is being developed by scientists at Volgograd State University (VolSU).
With its help, doctors will be able to determine not only the possible course of the disease, but also assess the use of various treatment methods, as well as understand how effective they will be.
The program is based on a mathematical model. It takes into account various cellular processes, including
the distribution of cells within the tumor, which will make it possible to understand more accurately how therapy affects its different areas.
In implementing the project, VolSU specialists were aided by support from the Russian Science Foundation, which addresses important problems in understanding the causes of the limited effectiveness of CAR-T therapy. This is a type of cancer immunotherapy in which the patient’s own T lymphocytes are genetically “reprogrammed” so that they find and destroy tumor cells.
Despite the successes of CAR-T therapy in treating blood cancers such as leukemias and lymphomas, its use for more complex tumors remains problematic. The search for ways to improve it has become an important task in cancer immunology. The specialists’ development may become the basis for future clinical decisions aimed at improving the quality and effectiveness of treatment for cancer patients.
Read more materials on the topic:
- A method for diagnosing malignant tumors was developed in Veliky Novgorod
- Nanoparticles for the precise destruction of cancerous tumors were created in Mordovia
- Detect a brain tumor and Alzheimer’s disease from CT scans: programmers from Russia are developing new software
